Skip to main content
. 2021 Nov 21;25(12):872–879. doi: 10.5152/AnatolJCardiol.2021.69299

Supplementary Table 2.

Baseline information of patients with AF with different outcomes

Variable Death outcome Stroke outcome

Death (24) Survivor (193) P-value Stroke (15) Without stroke (202) P-value
Age (years) 73.71±8.73 62.13±11.97 <0.001 69.93±9.77 62.93±12.24 0.032
Sex 0.982 0.993
 Male 13 (54.17%) 105 (44.40%) 8 (53.33%) 110 (54.46%)
 Female 11 (45.83%) 88 (45.60%) 7(46.67%) 92 (45.54%)
BMI (kg/m 2 ) 25.06±4.29 24.23±3.50 0.289 23.18±3.24 24.40±3.61 0.205
Income (10,000 RMB/year) 0.170 0.391
 <2.5 9 (37.50%) 101 (52.33%) 6 (40.00%) 104 (51.49%)
 ≥2.5 15 (62.50%) 92 (47.27%) 9 (60.00%) 98 (48.51%)
Smoking 7 (29.17%) 66 (34.20%) 0.623 3 (20.00%) 70 (34.65%) 0.246
Drinking 8 (33.33%) 68 (35.23%) 0.854 3 (20.00%) 73 (36.14%) 0.206
Treatment
 Warfarin 8 (33.33%) 57 (29.53%) 0.702 7 (46.67%) 58 (28.71%) 0.153
 Statins 14 (58.33%) 83 (43.01%) 0.154 8 (53.33%) 89 (44.06%) 0.486
Comorbidity
 Hypertension 16(66.67%) 93 (48.19%) 0.088 10 (66.67%) 99 (49.01%) 0.187
 Diabetes 5 (20.83%) 28 (14.51%) 0.379 6 (40.00%) 27 (13.37%) 0.014
 Coronary heart disease 14(58.33%) 69 (35.75%) 0.032 7 (46.67%) 76 (37.62%) 0.487
 Cardiomyopathy 4 (16.67%) 18 (9.33%) 0.278 0 (0.00%) 22 (10.89%) 0.374
 Heart failure 19(79.17%) 59 (30.57%) <0.001 7 (46.67%) 71 (35.15%) 0.370
 TIA 0 (0.00%) 9 (4.66%) 0.602 2 (13.33%) 7 (3.47%) 0.121
 Vascular diseases 2 (8.33%) 12 (6.22%) 0.657 2 (13.33%) 12 (5.94%) 0.250
 Previous stroke 2 (8.33%) 16 (8.29%) 1.000 5 (33.33%) 13 (6.44%) 0.004
Echocardiograhic parameters
 LAD, mm 49.74±8.37 44.28±9.76 0.001 50.2±11.14 44.47±9.54 0.028
 LVEDD, mm 57.47±10.69 50.63±8.23 0.007 51.07±8.09 51.43±8.85 0.879
 Left ventricular EF, % 45.52±12.94 56.65±12.81 <0.001 55.87±13.26 55.37±13.30 0.888

AF - atrial fibrillation; BMI - body mass index; EF - ejection fraction; LAD - left atrial diameter; LVEDD - left ventricular end diastolic diameter; TIA - transient ischemic attack